38th Annual J.P. Morgan




Video Play Button

Michael Gaito

J.P. Morgan's Head of Healthcare Investment Banking, Michael Gaito, discusses the environment for deal activity in 2020.
Transcript Button
Video Play Button

Chris Schott

The Senior Analyst for U.S. Major and Specialty Pharmaceuticals discusses how new technologies and drug pricing can be harnessed to meet unmet need in the pharma industry.
Transcript Button
Video Play Button

Lisa Gill

The Senior Analyst for Healthcare Technology and Distribution explains how the evolving needs of the consumer are disrupting the marketplace today.
Transcript Button
Healthcare in 2020: Key Themes for an Election Year
18:45 Healthcare remains a key issue for voters ahead of the 2020 elections, with drug pricing reform, patient affordability and the changing role of the consumer as major themes for both the U.S. pharmaceutical industry and the 2020 presidential candidates. J.P. Morgan Research explores the outlook for the industry in 2020 ahead of the election and beyond.


January 13-16, 2020

The J.P. Morgan Healthcare conference is for clients of the firm, by invitation only. Please reach out to your J.P. Morgan representative to inquire about an invitation

Registration closes prior to the conference date. There is no onsite registration.

Yes. Some company presentations will also be available via webcasts.

The agenda is made available only to confirmed attendees.

Yes; there are a limited number of press passes for the event.

All company presentations are considered on-the-record unless otherwise specified. Luncheon keynotes are off-the-record.